Status:

UNKNOWN

Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial

Lead Sponsor:

Larissa University Hospital

Conditions:

Acute Heart Failure

Eligibility:

All Genders

18-90 years

Phase:

PHASE4

Brief Summary

The aim of this study is to compare the effects of high-dose furosemide versus low-dose furosemide combined with low-dose dopamine on diuresis, renal function, electrolyte balance, and 60-day post-dis...

Detailed Description

Worsening renal function (WRF) and hypokalemia related to diuretic use for acute decompensated heart failure (ADHF) are common and portend poor prognosis. Low dose dopamine infusion improves renal per...

Eligibility Criteria

Inclusion

  • patients with New York Heart Association (NYHA) functional class IV heart failure according to the American Heart Association (AHA) classification, namely dyspnea on minimal exertion or rest dyspnea, orthopnea, and paroxysmal nocturnal dyspnea
  • signs of congestion (third heart sound or pulmonary rales on physical examination)
  • pulmonary congestion on chest x-ray
  • serum B-type natriuretic peptide levels \> 400 pg/ml or NT-proBNP \> 1500 pg/ml
  • echocardiographic documentation of systolic or diastolic dysfunction
  • all candidate patients must be:
  • Age \>18 years old
  • on medical therapy with an ACE-inhibitor and/or a β-blocker
  • experiencing an acute decompensation of known chronic HF
  • Having baseline oxygen saturation \<90% on admission arterial blood gas

Exclusion

  • the investigators will exclude patients with:
  • acute de novo HF
  • severe renal failure (serum creatinine \> 200 μmol/L or GFR \< 30 ml/min/1.73m2)
  • admission systolic blood pressure \< 90 mm Hg
  • severe valvular disease
  • known adverse reactions to furosemide or dopamine
  • HF secondary to congenital heart disease
  • a scheduled procedure with a need for IV contrast dye
  • a scheduled cardiac surgery within 6 months

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2012

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00937092

Start Date

January 1 2009

End Date

July 1 2012

Last Update

May 26 2010

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Department of Cardiology, Larissa University Hospital

Larissa, Larissa, Greece, 411 10

2

Department of Cardiology, Volos General Hospital

Volos, Magnesia, Greece, 382 21

Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial | DecenTrialz